Smartleaf Asset Management’s Avadel Pharmaceuticals AVDL Stock Holding History

Smartleaf Asset Management’s Portfolio AVDL Stock Details AVDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-30	Closed	-$646	–	3515
2025 Q4	$646	Buy	+30	New	+$582	﹤0.01%	3231
2025 Q1	–	Sell	-258	Closed	-$2.71K	–	2872
2024 Q4	$2.71K	Buy	+258	New	+$3.13K	﹤0.01%	2443

Other funds holding AVDL

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Smartleaf Asset Management's AVDL Position: Q1 2026 in Review

Smartleaf Asset Management sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 30 shares — an estimated $646 sold.

Smartleaf Asset Management first reported a position in AVDL in Q4 2024 and held it in 2 quarters. The position peaked at $2.71K in Q4 2024. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

Smartleaf Asset Management reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Smartleaf Asset Management sold 30 Avadel Pharmaceuticals shares in Q1 2026, an estimated $646.
Smartleaf Asset Management first reported a position in Avadel Pharmaceuticals in Q4 2024 and held it in 2 quarters.
Smartleaf Asset Management's Avadel Pharmaceuticals position peaked at $2.71K in Q4 2024.
2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.